

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endocrine pancreas development (GO:0031018) | 6.38744571 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.28236414 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.28236414 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.89093121 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.89093121 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.51814840 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.39831261 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.39831261 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.39831261 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.39831261 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.39831261 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.39831261 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.11459604 |
| 14 | regulation of platelet aggregation (GO:0090330) | 5.02648353 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.92049766 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 4.88157636 |
| 17 | response to peptidoglycan (GO:0032494) | 4.86151113 |
| 18 | signal peptide processing (GO:0006465) | 4.79693911 |
| 19 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.70019435 |
| 20 | definitive hemopoiesis (GO:0060216) | 4.63482868 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.50122733 |
| 22 | platelet aggregation (GO:0070527) | 4.45235977 |
| 23 | tyrosine metabolic process (GO:0006570) | 4.43318150 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.40294107 |
| 25 | regulation of histone phosphorylation (GO:0033127) | 4.39122777 |
| 26 | cellular response to leptin stimulus (GO:0044320) | 4.36193710 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 4.33093698 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 4.33093698 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.30158801 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 4.30095794 |
| 31 | response to host immune response (GO:0052572) | 4.30074254 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.30074254 |
| 33 | lipoxygenase pathway (GO:0019372) | 4.26999112 |
| 34 | protein retention in ER lumen (GO:0006621) | 4.24508181 |
| 35 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.23933630 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 4.17242219 |
| 37 | neutrophil activation (GO:0042119) | 4.16528194 |
| 38 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.14553831 |
| 39 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.14553831 |
| 40 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.08865759 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.06359179 |
| 42 | glandular epithelial cell differentiation (GO:0002067) | 4.04914226 |
| 43 | peptide hormone processing (GO:0016486) | 3.99812295 |
| 44 | defense response to protozoan (GO:0042832) | 3.95867319 |
| 45 | protein maturation by protein folding (GO:0022417) | 3.94854773 |
| 46 | superoxide anion generation (GO:0042554) | 3.94512678 |
| 47 | response to protozoan (GO:0001562) | 3.93482621 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.93061228 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.92628492 |
| 50 | regulation of fibrinolysis (GO:0051917) | 3.92532472 |
| 51 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.92270476 |
| 52 | urea cycle (GO:0000050) | 3.91365913 |
| 53 | urea metabolic process (GO:0019627) | 3.91365913 |
| 54 | tryptophan metabolic process (GO:0006568) | 3.85249763 |
| 55 | pentose-phosphate shunt (GO:0006098) | 3.84424364 |
| 56 | response to leptin (GO:0044321) | 3.81788927 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78264084 |
| 58 | response to host (GO:0075136) | 3.78264084 |
| 59 | response to host defenses (GO:0052200) | 3.78264084 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.73102186 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.72906449 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.72661323 |
| 63 | response to pheromone (GO:0019236) | 3.72650775 |
| 64 | regulation of hexokinase activity (GO:1903299) | 3.72606743 |
| 65 | regulation of glucokinase activity (GO:0033131) | 3.72606743 |
| 66 | pentose metabolic process (GO:0019321) | 3.70372266 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 3.66071281 |
| 68 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.64482945 |
| 69 | sequestering of metal ion (GO:0051238) | 3.64105383 |
| 70 | regulation of leukocyte degranulation (GO:0043300) | 3.62893170 |
| 71 | base-excision repair, AP site formation (GO:0006285) | 3.62788529 |
| 72 | complement activation, alternative pathway (GO:0006957) | 3.61252488 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.61234522 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 3.61234522 |
| 75 | tryptophan catabolic process (GO:0006569) | 3.61234522 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.60780271 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.59962581 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.59962581 |
| 79 | granulocyte activation (GO:0036230) | 3.59773020 |
| 80 | positive regulation of insulin secretion (GO:0032024) | 3.59354425 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.58609988 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 3.56745650 |
| 83 | regulation of platelet activation (GO:0010543) | 3.53797062 |
| 84 | germinal center formation (GO:0002467) | 3.52932411 |
| 85 | long term synaptic depression (GO:0060292) | 3.50193500 |
| 86 | sulfur amino acid catabolic process (GO:0000098) | 3.47945009 |
| 87 | COPII vesicle coating (GO:0048208) | 3.45316453 |
| 88 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.43765688 |
| 89 | homotypic cell-cell adhesion (GO:0034109) | 3.41709135 |
| 90 | type B pancreatic cell development (GO:0003323) | 3.41341985 |
| 91 | NADPH regeneration (GO:0006740) | 3.40127734 |
| 92 | negative regulation of interleukin-6 production (GO:0032715) | 3.39751871 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37153749 |
| 94 | megakaryocyte development (GO:0035855) | 3.34940436 |
| 95 | cysteine metabolic process (GO:0006534) | 3.34832427 |
| 96 | neutrophil mediated immunity (GO:0002446) | 3.34292357 |
| 97 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.33414950 |
| 98 | protein carboxylation (GO:0018214) | 3.33414950 |
| 99 | positive regulation of glycolytic process (GO:0045821) | 3.32322202 |
| 100 | glandular epithelial cell development (GO:0002068) | 3.31956720 |
| 101 | regulation of mitochondrial depolarization (GO:0051900) | 3.31002079 |
| 102 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.30803697 |
| 103 | kynurenine metabolic process (GO:0070189) | 3.30765687 |
| 104 | negative regulation of fibrinolysis (GO:0051918) | 3.29329668 |
| 105 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28825380 |
| 106 | regulation of integrin activation (GO:0033623) | 3.28662286 |
| 107 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.28288280 |
| 108 | high-density lipoprotein particle remodeling (GO:0034375) | 3.27539362 |
| 109 | glyoxylate metabolic process (GO:0046487) | 3.27460463 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24953083 |
| 111 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.23040539 |
| 112 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.21690104 |
| 113 | macrophage activation (GO:0042116) | 3.21338289 |
| 114 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.21064897 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20655478 |
| 116 | bile acid metabolic process (GO:0008206) | 3.19822232 |
| 117 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.19609797 |
| 118 | detection of light stimulus involved in visual perception (GO:0050908) | 3.19609797 |
| 119 | cellular extravasation (GO:0045123) | 3.19578471 |
| 120 | indolalkylamine metabolic process (GO:0006586) | 3.19519239 |
| 121 | epithelial cell fate commitment (GO:0072148) | 3.18297007 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 3.17690768 |
| 123 | negative regulation of phagocytosis (GO:0050765) | 3.17578936 |
| 124 | nucleoside diphosphate catabolic process (GO:0009134) | 3.17340036 |
| 125 | drug transmembrane transport (GO:0006855) | 3.16442683 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 3.14569439 |
| 127 | positive regulation of peptide hormone secretion (GO:0090277) | 3.14447494 |
| 128 | regulation of protein activation cascade (GO:2000257) | 3.13979084 |
| 129 | negative regulation of innate immune response (GO:0045824) | 3.13755237 |
| 130 | insulin secretion (GO:0030073) | 3.13555489 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 3.13201533 |
| 132 | bile acid biosynthetic process (GO:0006699) | 3.12364665 |
| 133 | regulation of regulated secretory pathway (GO:1903305) | 3.09527771 |
| 134 | regulation of insulin secretion (GO:0050796) | 3.09522450 |
| 135 | valine metabolic process (GO:0006573) | 3.08867048 |
| 136 | regulation of erythrocyte differentiation (GO:0045646) | 3.08733044 |
| 137 | aldehyde catabolic process (GO:0046185) | 3.07920570 |
| 138 | bile acid and bile salt transport (GO:0015721) | 3.07698293 |
| 139 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.07408891 |
| 140 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.07008292 |
| 141 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.07001123 |
| 142 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.04637976 |
| 143 | respiratory burst (GO:0045730) | 3.04588551 |
| 144 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04407390 |
| 145 | negative regulation of cell killing (GO:0031342) | 3.04407390 |
| 146 | regulation of mast cell activation (GO:0033003) | 3.03880692 |
| 147 | reverse cholesterol transport (GO:0043691) | 3.02744786 |
| 148 | positive regulation of peptide secretion (GO:0002793) | 3.02119562 |
| 149 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.01260353 |
| 150 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.01260353 |
| 151 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.01260353 |
| 152 | regulation of bile acid biosynthetic process (GO:0070857) | 3.00139771 |
| 153 | toxin metabolic process (GO:0009404) | 2.99441472 |
| 154 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95302592 |
| 155 | leukocyte degranulation (GO:0043299) | 2.95293113 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94194699 |
| 157 | hepatocyte apoptotic process (GO:0097284) | 2.94190639 |
| 158 | acute-phase response (GO:0006953) | 2.93775941 |
| 159 | alkaloid metabolic process (GO:0009820) | 2.93727867 |
| 160 | deoxyribose phosphate catabolic process (GO:0046386) | 2.93520051 |
| 161 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.92560263 |
| 162 | glucosamine-containing compound catabolic process (GO:1901072) | 2.90481266 |
| 163 | regulation of peptide hormone secretion (GO:0090276) | 2.90446322 |
| 164 | regulation of complement activation (GO:0030449) | 2.89797046 |
| 165 | cholesterol catabolic process (GO:0006707) | 2.89322981 |
| 166 | sterol catabolic process (GO:0016127) | 2.89322981 |
| 167 | leukocyte aggregation (GO:0070486) | 2.88975091 |
| 168 | negative regulation of bone resorption (GO:0045779) | 2.88595591 |
| 169 | regulation of peptide secretion (GO:0002791) | 2.85089695 |
| 170 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84705501 |
| 171 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.83396435 |
| 172 | cholesterol efflux (GO:0033344) | 2.83302312 |
| 173 | protein activation cascade (GO:0072376) | 2.83045311 |
| 174 | microglial cell activation (GO:0001774) | 2.83017879 |
| 175 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.82854468 |
| 176 | presynaptic membrane assembly (GO:0097105) | 2.82565592 |
| 177 | protein autoprocessing (GO:0016540) | 2.81338338 |
| 178 | positive regulation of interferon-alpha production (GO:0032727) | 2.81158508 |
| 179 | glucose catabolic process (GO:0006007) | 2.81087780 |
| 180 | alpha-amino acid catabolic process (GO:1901606) | 2.80368218 |
| 181 | fibrinolysis (GO:0042730) | 2.80302719 |
| 182 | deoxyribonucleotide catabolic process (GO:0009264) | 2.79940511 |
| 183 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.79826605 |
| 184 | plasma lipoprotein particle remodeling (GO:0034369) | 2.79763936 |
| 185 | protein-lipid complex remodeling (GO:0034368) | 2.79763936 |
| 186 | macromolecular complex remodeling (GO:0034367) | 2.79763936 |
| 187 | regulation of oxidative phosphorylation (GO:0002082) | 2.79221279 |
| 188 | response to methylmercury (GO:0051597) | 2.78903382 |
| 189 | negative regulation of lipid catabolic process (GO:0050995) | 2.78259081 |
| 190 | regulation of cholesterol esterification (GO:0010872) | 2.78195266 |
| 191 | positive regulation of regulated secretory pathway (GO:1903307) | 2.77861989 |
| 192 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.77470788 |
| 193 | negative regulation of interleukin-12 production (GO:0032695) | 2.76551120 |
| 194 | phospholipid efflux (GO:0033700) | 2.74831382 |
| 195 | negative regulation of granulocyte differentiation (GO:0030853) | 2.74731063 |
| 196 | positive regulation of mast cell activation (GO:0033005) | 2.74184226 |
| 197 | amyloid precursor protein catabolic process (GO:0042987) | 2.72718070 |
| 198 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67602012 |
| 199 | positive regulation of mast cell degranulation (GO:0043306) | 2.67602012 |
| 200 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.67369876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.57079528 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.02642534 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.93330461 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65333775 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.58441021 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.53776481 |
| 7 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.82667704 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.68739504 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.66554594 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.64416507 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.56016280 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.51988297 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.38275561 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24586621 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95153900 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.83416672 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.76166585 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.57886953 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46642246 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.45109180 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37161544 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34588130 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29061686 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.23548988 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.21561894 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20820450 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15945435 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.13457181 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11684245 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.07918790 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03327891 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01858639 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01751650 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01137926 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99331473 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96867048 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96741061 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91784831 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91561144 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.91143218 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.85851260 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82246635 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.81253741 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79138936 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72686375 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.72150460 |
| 47 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.70980499 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70606286 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70413388 |
| 50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68276321 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66873997 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.65716819 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65696008 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65556281 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63419416 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59351845 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57662243 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54082506 |
| 59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53028372 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51500912 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.48633355 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48409975 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47666283 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.47265976 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46508516 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.46402658 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46250776 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45210837 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43733429 |
| 70 | MYB_26560356_Chip-Seq_TH1_Human | 1.42938729 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40860243 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40567397 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40349557 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40231133 |
| 75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39648829 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37605159 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.36603079 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36234554 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35485224 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35480130 |
| 81 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.35051582 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32905684 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31273243 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31001524 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30036318 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29561882 |
| 87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.29346137 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28812272 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26335152 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25852778 |
| 91 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.23623195 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23567319 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23014345 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.22350013 |
| 95 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20650718 |
| 96 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.20598087 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20544375 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20486864 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20117662 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19562215 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18528722 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.18440444 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.16991618 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16971998 |
| 105 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16011673 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15451738 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15299926 |
| 108 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13950228 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13420753 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13338388 |
| 111 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12888420 |
| 112 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12677555 |
| 113 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12454953 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12324596 |
| 115 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12123568 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11946598 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11727696 |
| 118 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11611717 |
| 119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11142285 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10982882 |
| 121 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10897664 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08525655 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08190199 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08159436 |
| 125 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.07984996 |
| 126 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05230913 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04841863 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04610609 |
| 129 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04222770 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04058196 |
| 131 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03888190 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02833553 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01240112 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00677523 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00109944 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00039594 |
| 137 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.99059773 |
| 138 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.98851504 |
| 139 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98576765 |
| 140 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96828670 |
| 141 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96226772 |
| 142 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95814965 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95463813 |
| 144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94148755 |
| 145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94070811 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92241565 |
| 147 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90612286 |
| 148 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86476444 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82356436 |
| 150 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81576434 |
| 151 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.78794941 |
| 152 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77293930 |
| 153 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76653027 |
| 154 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75403338 |
| 155 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75403338 |
| 156 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75036990 |
| 157 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73583023 |
| 158 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73311145 |
| 159 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.72435593 |
| 160 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.72315943 |
| 161 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69773158 |
| 162 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.67651566 |
| 163 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.67319342 |
| 164 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.67055783 |
| 165 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.66748702 |
| 166 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65654375 |
| 167 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64859410 |
| 168 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.64135640 |
| 169 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.63455215 |
| 170 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.63423269 |
| 171 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.63070188 |
| 172 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.63069605 |
| 173 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.62739231 |
| 174 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.61446249 |
| 175 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61362937 |
| 176 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.60936543 |
| 177 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.60936543 |
| 178 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.60319004 |
| 179 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.60042484 |
| 180 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.59848945 |
| 181 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.59589582 |
| 182 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59443549 |
| 183 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59389970 |
| 184 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.58272586 |
| 185 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58025039 |
| 186 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58025039 |
| 187 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.58016864 |
| 188 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57922679 |
| 189 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.57658946 |
| 190 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57506568 |
| 191 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.57404324 |
| 192 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57242035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000465_gastrointestinal_hemorrhage | 7.12365089 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.29776689 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.68412111 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.49773730 |
| 5 | MP0005365_abnormal_bile_salt | 4.10988157 |
| 6 | MP0010386_abnormal_urinary_bladder | 4.08494583 |
| 7 | MP0000013_abnormal_adipose_tissue | 3.84456237 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.74640588 |
| 9 | MP0003195_calcinosis | 3.69689189 |
| 10 | MP0003724_increased_susceptibility_to | 3.60135463 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 3.41213667 |
| 12 | MP0005360_urolithiasis | 3.36529480 |
| 13 | MP0004043_abnormal_pH_regulation | 3.30931718 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 3.29148495 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 3.28045897 |
| 16 | MP0003436_decreased_susceptibility_to | 3.17241186 |
| 17 | MP0002396_abnormal_hematopoietic_system | 3.03364533 |
| 18 | MP0002693_abnormal_pancreas_physiology | 3.00613791 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.99405423 |
| 20 | MP0003868_abnormal_feces_composition | 2.94505546 |
| 21 | MP0003252_abnormal_bile_duct | 2.91336543 |
| 22 | MP0003303_peritoneal_inflammation | 2.80877153 |
| 23 | MP0001944_abnormal_pancreas_morphology | 2.72308350 |
| 24 | MP0002132_abnormal_respiratory_system | 2.56831055 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 2.56202129 |
| 26 | MP0002876_abnormal_thyroid_physiology | 2.51865616 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 2.39704905 |
| 28 | MP0008260_abnormal_autophagy | 2.36460878 |
| 29 | MP0002419_abnormal_innate_immunity | 2.35134000 |
| 30 | MP0005220_abnormal_exocrine_pancreas | 2.25206136 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 2.23904731 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 2.23040332 |
| 33 | MP0001545_abnormal_hematopoietic_system | 2.23040332 |
| 34 | MP0001348_abnormal_lacrimal_gland | 2.20655030 |
| 35 | MP0005025_abnormal_response_to | 2.16836720 |
| 36 | MP0006072_abnormal_retinal_apoptosis | 2.15995097 |
| 37 | MP0001835_abnormal_antigen_presentation | 2.11337799 |
| 38 | MP0003172_abnormal_lysosome_physiology | 2.11317857 |
| 39 | MP0010329_abnormal_lipoprotein_level | 2.09037782 |
| 40 | MP0005379_endocrine/exocrine_gland_phen | 2.08928134 |
| 41 | MP0002909_abnormal_adrenal_gland | 2.07362826 |
| 42 | MP0009278_abnormal_bone_marrow | 2.00880702 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.99761777 |
| 44 | MP0005451_abnormal_body_composition | 1.97080830 |
| 45 | MP0001800_abnormal_humoral_immune | 1.93330111 |
| 46 | MP0002723_abnormal_immune_serum | 1.88103754 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.88036892 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 1.86932929 |
| 49 | MP0001819_abnormal_immune_cell | 1.86862264 |
| 50 | MP0002398_abnormal_bone_marrow | 1.77892132 |
| 51 | MP0002722_abnormal_immune_system | 1.76770753 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.76696522 |
| 53 | MP0003283_abnormal_digestive_organ | 1.76022345 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.72178278 |
| 55 | MP0001853_heart_inflammation | 1.71857716 |
| 56 | MP0003866_abnormal_defecation | 1.71822629 |
| 57 | MP0001666_abnormal_nutrient_absorption | 1.70196594 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.69788957 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.69362944 |
| 60 | MP0005332_abnormal_amino_acid | 1.66716141 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.66386054 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.66219111 |
| 63 | MP0000609_abnormal_liver_physiology | 1.61634826 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.58897407 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.53004532 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.50279011 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.50119327 |
| 68 | MP0000716_abnormal_immune_system | 1.49856456 |
| 69 | MP0001764_abnormal_homeostasis | 1.49432136 |
| 70 | MP0002429_abnormal_blood_cell | 1.46675205 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.45885486 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.45326041 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.43839712 |
| 74 | MP0008004_abnormal_stomach_pH | 1.43585062 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.40793642 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.39486938 |
| 77 | MP0009785_altered_susceptibility_to | 1.38998017 |
| 78 | MP0000579_abnormal_nail_morphology | 1.34813075 |
| 79 | MP0000678_abnormal_parathyroid_gland | 1.32880264 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.30873822 |
| 81 | MP0003828_pulmonary_edema | 1.28490118 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 1.27572429 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.26974905 |
| 84 | MP0000685_abnormal_immune_system | 1.25148219 |
| 85 | MP0005083_abnormal_biliary_tract | 1.24134400 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.23403854 |
| 87 | MP0002405_respiratory_system_inflammati | 1.22096610 |
| 88 | MP0001790_abnormal_immune_system | 1.21398047 |
| 89 | MP0005387_immune_system_phenotype | 1.21398047 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.21103063 |
| 91 | MP0004381_abnormal_hair_follicle | 1.20267255 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 1.19903003 |
| 93 | MP0005058_abnormal_lysosome_morphology | 1.18958879 |
| 94 | MP0004947_skin_inflammation | 1.16272952 |
| 95 | MP0003763_abnormal_thymus_physiology | 1.14388772 |
| 96 | MP0000538_abnormal_urinary_bladder | 1.14219581 |
| 97 | MP0005310_abnormal_salivary_gland | 1.11582836 |
| 98 | MP0008874_decreased_physiological_sensi | 1.11015498 |
| 99 | MP0005666_abnormal_adipose_tissue | 1.10407637 |
| 100 | MP0001756_abnormal_urination | 1.10336391 |
| 101 | MP0005535_abnormal_body_temperature | 1.10288524 |
| 102 | MP0005671_abnormal_response_to | 1.10197525 |
| 103 | MP0003953_abnormal_hormone_level | 1.10090891 |
| 104 | MP0003646_muscle_fatigue | 1.08418823 |
| 105 | MP0003693_abnormal_embryo_hatching | 1.07686021 |
| 106 | MP0003300_gastrointestinal_ulcer | 1.06881784 |
| 107 | MP0009840_abnormal_foam_cell | 1.06697329 |
| 108 | MP0009764_decreased_sensitivity_to | 1.06372017 |
| 109 | MP0003123_paternal_imprinting | 1.04956838 |
| 110 | MP0001765_abnormal_ion_homeostasis | 1.04768878 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.99815858 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.97101910 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.95422523 |
| 114 | MP0005253_abnormal_eye_physiology | 0.94362186 |
| 115 | MP0005501_abnormal_skin_physiology | 0.91198689 |
| 116 | MP0005408_hypopigmentation | 0.91096740 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.90813604 |
| 118 | MP0001873_stomach_inflammation | 0.90335264 |
| 119 | MP0002163_abnormal_gland_morphology | 0.90326494 |
| 120 | MP0001663_abnormal_digestive_system | 0.90094882 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.88161362 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88157450 |
| 123 | MP0000313_abnormal_cell_death | 0.86999366 |
| 124 | MP0003075_altered_response_to | 0.85742745 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.84400814 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.83989388 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.82258638 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.81253373 |
| 129 | MP0005075_abnormal_melanosome_morpholog | 0.80674874 |
| 130 | MP0002019_abnormal_tumor_incidence | 0.78292224 |
| 131 | MP0006082_CNS_inflammation | 0.77420367 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.76642821 |
| 133 | MP0003787_abnormal_imprinting | 0.76630382 |
| 134 | MP0002735_abnormal_chemical_nociception | 0.75091127 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.75028404 |
| 136 | MP0009672_abnormal_birth_weight | 0.74901649 |
| 137 | MP0004883_abnormal_blood_vessel | 0.74668070 |
| 138 | MP0000639_abnormal_adrenal_gland | 0.74377473 |
| 139 | MP0003186_abnormal_redox_activity | 0.73842215 |
| 140 | MP0010307_abnormal_tumor_latency | 0.71290617 |
| 141 | MP0004130_abnormal_muscle_cell | 0.70849268 |
| 142 | MP0000750_abnormal_muscle_regeneration | 0.70807154 |
| 143 | MP0002751_abnormal_autonomic_nervous | 0.69616555 |
| 144 | MP0003638_abnormal_response/metabolism_ | 0.69450895 |
| 145 | MP0009697_abnormal_copulation | 0.69081724 |
| 146 | MP0002254_reproductive_system_inflammat | 0.68307930 |
| 147 | MP0000858_altered_metastatic_potential | 0.68180638 |
| 148 | MP0003329_amyloid_beta_deposits | 0.67204124 |
| 149 | MP0003011_delayed_dark_adaptation | 0.66271783 |
| 150 | MP0002928_abnormal_bile_duct | 0.65829394 |
| 151 | MP0000470_abnormal_stomach_morphology | 0.65498787 |
| 152 | MP0001177_atelectasis | 0.64961292 |
| 153 | MP0003879_abnormal_hair_cell | 0.64035715 |
| 154 | MP0009931_abnormal_skin_appearance | 0.63860505 |
| 155 | MP0005334_abnormal_fat_pad | 0.63857677 |
| 156 | MP0005646_abnormal_pituitary_gland | 0.63096384 |
| 157 | MP0002736_abnormal_nociception_after | 0.62686495 |
| 158 | MP0000604_amyloidosis | 0.62107321 |
| 159 | MP0000598_abnormal_liver_morphology | 0.62015790 |
| 160 | MP0009763_increased_sensitivity_to | 0.60123358 |
| 161 | MP0003448_altered_tumor_morphology | 0.59695389 |
| 162 | MP0003121_genomic_imprinting | 0.58612211 |
| 163 | MP0001664_abnormal_digestion | 0.58117970 |
| 164 | MP0003656_abnormal_erythrocyte_physiolo | 0.57623255 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.56668086 |
| 166 | MP0002896_abnormal_bone_mineralization | 0.56289383 |
| 167 | MP0003705_abnormal_hypodermis_morpholog | 0.54491789 |
| 168 | MP0004270_analgesia | 0.53403854 |
| 169 | MP0005375_adipose_tissue_phenotype | 0.52495868 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.51683259 |
| 171 | MP0005448_abnormal_energy_balance | 0.51096911 |
| 172 | MP0006292_abnormal_olfactory_placode | 0.50444742 |
| 173 | MP0000613_abnormal_salivary_gland | 0.49421982 |
| 174 | MP0010368_abnormal_lymphatic_system | 0.49240466 |
| 175 | MP0000631_abnormal_neuroendocrine_gland | 0.47523117 |
| 176 | MP0008469_abnormal_protein_level | 0.46996739 |
| 177 | MP0005084_abnormal_gallbladder_morpholo | 0.46610042 |
| 178 | MP0008961_abnormal_basal_metabolism | 0.43409238 |
| 179 | MP0001661_extended_life_span | 0.42895469 |
| 180 | MP0001881_abnormal_mammary_gland | 0.42716116 |
| 181 | MP0009703_decreased_birth_body | 0.41713716 |
| 182 | MP0003959_abnormal_lean_body | 0.41666816 |
| 183 | MP0001851_eye_inflammation | 0.41042945 |
| 184 | MP0002971_abnormal_brown_adipose | 0.39966159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.65794543 |
| 2 | Abnormal platelet volume (HP:0011876) | 7.63138436 |
| 3 | Prolonged bleeding time (HP:0003010) | 7.54191157 |
| 4 | Increased mean platelet volume (HP:0011877) | 7.47664841 |
| 5 | Purpura (HP:0000979) | 6.70656669 |
| 6 | Menorrhagia (HP:0000132) | 6.57960081 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.39185035 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.21530936 |
| 9 | Hypoglycemic seizures (HP:0002173) | 6.18994572 |
| 10 | Hypoglycemic coma (HP:0001325) | 5.54712305 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.52028173 |
| 12 | Recurrent abscess formation (HP:0002722) | 5.47900271 |
| 13 | Gingival bleeding (HP:0000225) | 5.16276901 |
| 14 | Symptomatic seizures (HP:0011145) | 5.11186993 |
| 15 | Epistaxis (HP:0000421) | 4.87509091 |
| 16 | Abnormal platelet function (HP:0011869) | 4.84984792 |
| 17 | Impaired platelet aggregation (HP:0003540) | 4.84984792 |
| 18 | Joint hemorrhage (HP:0005261) | 4.79625049 |
| 19 | Obstructive lung disease (HP:0006536) | 4.70950374 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 4.70950374 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 4.67892651 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 4.53804964 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 4.45955625 |
| 24 | Hyperthyroidism (HP:0000836) | 4.44102453 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.41712348 |
| 26 | Mucopolysacchariduria (HP:0008155) | 4.20429375 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.20429375 |
| 28 | Deep venous thrombosis (HP:0002625) | 3.89902104 |
| 29 | Hyperglycemia (HP:0003074) | 3.84660412 |
| 30 | Ketoacidosis (HP:0001993) | 3.80038783 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76365554 |
| 32 | Late onset (HP:0003584) | 3.75350578 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.75329993 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.74803511 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.74803511 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.74803511 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.37378021 |
| 38 | Recurrent skin infections (HP:0001581) | 3.35365776 |
| 39 | Complement deficiency (HP:0004431) | 3.33521679 |
| 40 | Myositis (HP:0100614) | 3.31904701 |
| 41 | Seborrheic dermatitis (HP:0001051) | 3.31474712 |
| 42 | Recurrent fungal infections (HP:0002841) | 3.31362125 |
| 43 | Xanthomatosis (HP:0000991) | 3.27749087 |
| 44 | Ketosis (HP:0001946) | 3.20774285 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18052398 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18052398 |
| 47 | Dysostosis multiplex (HP:0000943) | 3.17980474 |
| 48 | Large for gestational age (HP:0001520) | 3.15394191 |
| 49 | Stomatitis (HP:0010280) | 3.14271590 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 3.10366198 |
| 51 | Hypertensive crisis (HP:0100735) | 3.05153607 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 3.02280584 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.97114794 |
| 54 | Global brain atrophy (HP:0002283) | 2.96727458 |
| 55 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.94188017 |
| 56 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.94188017 |
| 57 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91084911 |
| 58 | Epidermoid cyst (HP:0200040) | 2.90294344 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83825011 |
| 60 | Orchitis (HP:0100796) | 2.81453642 |
| 61 | Meningitis (HP:0001287) | 2.76740474 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72011060 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.70730913 |
| 64 | Limb hypertonia (HP:0002509) | 2.68128533 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.67592425 |
| 66 | Viral hepatitis (HP:0006562) | 2.63756323 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.63664591 |
| 68 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.63632413 |
| 69 | Cervical subluxation (HP:0003308) | 2.61652894 |
| 70 | Spastic paraparesis (HP:0002313) | 2.57238440 |
| 71 | Episodic fever (HP:0001954) | 2.56961554 |
| 72 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.56405131 |
| 73 | Meningioma (HP:0002858) | 2.55914348 |
| 74 | Hypobetalipoproteinemia (HP:0003563) | 2.55507899 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.54727041 |
| 76 | Chronic otitis media (HP:0000389) | 2.53252502 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.51317424 |
| 78 | Agitation (HP:0000713) | 2.51179634 |
| 79 | Cellulitis (HP:0100658) | 2.47618665 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.46754772 |
| 81 | Cutaneous melanoma (HP:0012056) | 2.46555852 |
| 82 | Split foot (HP:0001839) | 2.46253350 |
| 83 | Hepatosplenomegaly (HP:0001433) | 2.45854055 |
| 84 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43651693 |
| 85 | Hypoparathyroidism (HP:0000829) | 2.43562926 |
| 86 | Recurrent viral infections (HP:0004429) | 2.43104991 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.41561764 |
| 88 | Urticaria (HP:0001025) | 2.41193789 |
| 89 | Severe visual impairment (HP:0001141) | 2.40724431 |
| 90 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.37921973 |
| 91 | Encephalitis (HP:0002383) | 2.36309376 |
| 92 | Generalized hyperpigmentation (HP:0007440) | 2.35894692 |
| 93 | Fat malabsorption (HP:0002630) | 2.35179580 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.35031505 |
| 95 | Optic neuritis (HP:0100653) | 2.35031505 |
| 96 | Gout (HP:0001997) | 2.32792658 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.31906380 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.29706857 |
| 99 | Abnormality of complement system (HP:0005339) | 2.29348158 |
| 100 | Gingivitis (HP:0000230) | 2.29139231 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 2.27079184 |
| 102 | Hypothermia (HP:0002045) | 2.26694990 |
| 103 | Truncus arteriosus (HP:0001660) | 2.26282830 |
| 104 | Leukocytosis (HP:0001974) | 2.26225796 |
| 105 | Insulin resistance (HP:0000855) | 2.25889621 |
| 106 | Disproportionate short-trunk short stature (HP:0003521) | 2.24872381 |
| 107 | Irritability (HP:0000737) | 2.24115698 |
| 108 | Decreased circulating renin level (HP:0003351) | 2.23218246 |
| 109 | Mitral stenosis (HP:0001718) | 2.22765712 |
| 110 | Tetraparesis (HP:0002273) | 2.22593274 |
| 111 | Acute lymphatic leukemia (HP:0006721) | 2.22138983 |
| 112 | Gastrointestinal infarctions (HP:0005244) | 2.20175272 |
| 113 | Increased IgE level (HP:0003212) | 2.19924607 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 2.19521525 |
| 115 | Micronodular cirrhosis (HP:0001413) | 2.18889554 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 2.18583877 |
| 117 | Beaking of vertebral bodies (HP:0004568) | 2.16513384 |
| 118 | Hyperkalemia (HP:0002153) | 2.15186284 |
| 119 | Abnormality of macular pigmentation (HP:0008002) | 2.13791624 |
| 120 | Hyperbilirubinemia (HP:0002904) | 2.13585095 |
| 121 | Conjunctival hamartoma (HP:0100780) | 2.09317723 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 2.08847146 |
| 123 | Arterial thrombosis (HP:0004420) | 2.08813194 |
| 124 | Impaired proprioception (HP:0010831) | 2.08664089 |
| 125 | Agammaglobulinemia (HP:0004432) | 2.07496901 |
| 126 | Cholecystitis (HP:0001082) | 2.05932149 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 2.05932149 |
| 128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05808405 |
| 129 | Colitis (HP:0002583) | 2.05392975 |
| 130 | Neurodegeneration (HP:0002180) | 2.04574797 |
| 131 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02893835 |
| 132 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00729510 |
| 133 | Enlarged kidneys (HP:0000105) | 2.00140691 |
| 134 | Testicular atrophy (HP:0000029) | 1.99265243 |
| 135 | Hypolipoproteinemia (HP:0010981) | 1.97698240 |
| 136 | Abnormality of the thymus (HP:0000777) | 1.97133551 |
| 137 | Abnormality of the peritoneum (HP:0002585) | 1.94289659 |
| 138 | Bowel incontinence (HP:0002607) | 1.93260206 |
| 139 | Ovoid vertebral bodies (HP:0003300) | 1.92900563 |
| 140 | Bone cyst (HP:0012062) | 1.92035498 |
| 141 | Abnormality of T cell physiology (HP:0011840) | 1.91591261 |
| 142 | Paraparesis (HP:0002385) | 1.91471184 |
| 143 | Pheochromocytoma (HP:0002666) | 1.91405630 |
| 144 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91228268 |
| 145 | Glomerulonephritis (HP:0000099) | 1.91123201 |
| 146 | Hyperglycinemia (HP:0002154) | 1.90842246 |
| 147 | Abnormality of the tricuspid valve (HP:0001702) | 1.90457930 |
| 148 | Abnormal large intestine physiology (HP:0012700) | 1.90448048 |
| 149 | Atelectasis (HP:0100750) | 1.90095859 |
| 150 | Chest pain (HP:0100749) | 1.89733700 |
| 151 | Cerebral edema (HP:0002181) | 1.89715130 |
| 152 | Hypoalphalipoproteinemia (HP:0003233) | 1.89524776 |
| 153 | Hyperammonemia (HP:0001987) | 1.89056469 |
| 154 | Abnormality of proline metabolism (HP:0010907) | 1.89034988 |
| 155 | Hydroxyprolinuria (HP:0003080) | 1.89034988 |
| 156 | Hypocalcemia (HP:0002901) | 1.88735172 |
| 157 | Increased serum ferritin (HP:0003281) | 1.88143303 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.84003894 |
| 159 | Glycosuria (HP:0003076) | 1.84003894 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83695028 |
| 161 | Alkalosis (HP:0001948) | 1.82775322 |
| 162 | Acne (HP:0001061) | 1.82634335 |
| 163 | Abnormal protein glycosylation (HP:0012346) | 1.82200144 |
| 164 | Abnormal glycosylation (HP:0012345) | 1.82200144 |
| 165 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.82200144 |
| 166 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.82200144 |
| 167 | Osteomalacia (HP:0002749) | 1.81583745 |
| 168 | Skin nodule (HP:0200036) | 1.80746991 |
| 169 | Congenital glaucoma (HP:0001087) | 1.80187892 |
| 170 | Lethargy (HP:0001254) | 1.79456187 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79304234 |
| 172 | Hypochromic anemia (HP:0001931) | 1.78761695 |
| 173 | Progressive neurologic deterioration (HP:0002344) | 1.78235554 |
| 174 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.77867848 |
| 175 | Hyperglycinuria (HP:0003108) | 1.76916735 |
| 176 | Type I transferrin isoform profile (HP:0003642) | 1.75068569 |
| 177 | Delayed CNS myelination (HP:0002188) | 1.74437989 |
| 178 | Tinnitus (HP:0000360) | 1.72777734 |
| 179 | Pancreatitis (HP:0001733) | 1.71496192 |
| 180 | Hepatitis (HP:0012115) | 1.71321508 |
| 181 | Abdominal distention (HP:0003270) | 1.70138238 |
| 182 | Polygenic inheritance (HP:0010982) | 1.69706213 |
| 183 | Hyperactive renin-angiotensin system (HP:0000841) | 1.69047751 |
| 184 | Intestinal atresia (HP:0011100) | 1.68634458 |
| 185 | Acute myeloid leukemia (HP:0004808) | 1.68204380 |
| 186 | Anteriorly placed anus (HP:0001545) | 1.67629877 |
| 187 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.66903442 |
| 188 | Bruising susceptibility (HP:0000978) | 1.66676156 |
| 189 | Granulocytopenia (HP:0001913) | 1.63899909 |
| 190 | Elevated alkaline phosphatase (HP:0003155) | 1.63497836 |
| 191 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.62389935 |
| 192 | Respiratory difficulties (HP:0002880) | 1.62222379 |
| 193 | Amyloidosis (HP:0011034) | 1.61679320 |
| 194 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60406052 |
| 195 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.59349680 |
| 196 | Vasculitis (HP:0002633) | 1.56777596 |
| 197 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.53773435 |
| 198 | Abnormality of T cells (HP:0002843) | 1.53677531 |
| 199 | Microcytic anemia (HP:0001935) | 1.53534185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME1 | 5.08942193 |
| 2 | IRAK2 | 4.75745537 |
| 3 | INSRR | 4.75064064 |
| 4 | STK16 | 4.69908514 |
| 5 | MAP2K3 | 3.45609473 |
| 6 | TRIB3 | 3.44254026 |
| 7 | IRAK4 | 3.32626294 |
| 8 | TESK2 | 3.08043792 |
| 9 | WNK4 | 2.99201985 |
| 10 | FRK | 2.71480785 |
| 11 | RIPK4 | 2.60686186 |
| 12 | VRK2 | 2.59931246 |
| 13 | MAP3K11 | 2.53046488 |
| 14 | GRK6 | 2.52572026 |
| 15 | PASK | 2.49815552 |
| 16 | BRAF | 2.45770957 |
| 17 | MAPK15 | 2.41496211 |
| 18 | SIK3 | 2.30192824 |
| 19 | HIPK2 | 2.28092760 |
| 20 | MAP2K2 | 2.23226092 |
| 21 | MAP3K2 | 2.21268484 |
| 22 | PKN2 | 2.19318047 |
| 23 | TAOK3 | 2.13557519 |
| 24 | TBK1 | 2.11897936 |
| 25 | KIT | 2.04388497 |
| 26 | MAP4K1 | 1.98894884 |
| 27 | BCKDK | 1.97663755 |
| 28 | FES | 1.79109577 |
| 29 | BLK | 1.72135444 |
| 30 | ERN1 | 1.65010384 |
| 31 | ARAF | 1.64906984 |
| 32 | SMG1 | 1.63230566 |
| 33 | PTK6 | 1.55841410 |
| 34 | TXK | 1.55601813 |
| 35 | IKBKE | 1.54904538 |
| 36 | ZAP70 | 1.52245502 |
| 37 | FLT3 | 1.51533305 |
| 38 | SIK2 | 1.49248134 |
| 39 | IKBKB | 1.41422387 |
| 40 | TLK1 | 1.40796951 |
| 41 | RPS6KB2 | 1.38708371 |
| 42 | WNK3 | 1.36814654 |
| 43 | DYRK1A | 1.29195759 |
| 44 | IRAK1 | 1.26647148 |
| 45 | NTRK3 | 1.26330269 |
| 46 | BTK | 1.24395325 |
| 47 | SYK | 1.21956661 |
| 48 | DYRK1B | 1.21498426 |
| 49 | RIPK1 | 1.20420737 |
| 50 | SCYL2 | 1.18937567 |
| 51 | CDC42BPA | 1.18717369 |
| 52 | BMPR2 | 1.17770273 |
| 53 | ACVR1B | 1.16339715 |
| 54 | HCK | 1.16067062 |
| 55 | KSR2 | 1.14504107 |
| 56 | CSK | 1.13325830 |
| 57 | MAP3K3 | 1.12489666 |
| 58 | TEC | 1.08889356 |
| 59 | FGFR4 | 1.04575609 |
| 60 | EPHB1 | 1.00957065 |
| 61 | PIK3CG | 0.99428841 |
| 62 | MATK | 0.98401358 |
| 63 | CSF1R | 0.98224195 |
| 64 | LYN | 0.96706797 |
| 65 | LRRK2 | 0.95968413 |
| 66 | ZAK | 0.94141251 |
| 67 | MAP2K1 | 0.93731690 |
| 68 | RPS6KA6 | 0.92261404 |
| 69 | NTRK1 | 0.88364522 |
| 70 | BMPR1B | 0.87585880 |
| 71 | UHMK1 | 0.86511934 |
| 72 | ERBB4 | 0.86086615 |
| 73 | TAOK2 | 0.86032337 |
| 74 | PRKD3 | 0.85860642 |
| 75 | WNK1 | 0.80857529 |
| 76 | RPS6KC1 | 0.79643594 |
| 77 | RPS6KL1 | 0.79643594 |
| 78 | EPHA2 | 0.79201844 |
| 79 | GSK3A | 0.77883794 |
| 80 | MET | 0.77759548 |
| 81 | CDK7 | 0.76230353 |
| 82 | MAP2K6 | 0.75566265 |
| 83 | STK38L | 0.74649497 |
| 84 | LCK | 0.74531749 |
| 85 | PRPF4B | 0.74092831 |
| 86 | CAMKK1 | 0.73343325 |
| 87 | YES1 | 0.71827842 |
| 88 | CAMKK2 | 0.71812249 |
| 89 | PDPK1 | 0.71441569 |
| 90 | EPHA3 | 0.69009356 |
| 91 | PRKD2 | 0.68416831 |
| 92 | NUAK1 | 0.68316835 |
| 93 | NLK | 0.66198807 |
| 94 | ITK | 0.66077600 |
| 95 | PRKCE | 0.65989464 |
| 96 | JAK2 | 0.64995834 |
| 97 | MAP3K6 | 0.60980577 |
| 98 | TAOK1 | 0.60698309 |
| 99 | JAK1 | 0.60374449 |
| 100 | DAPK2 | 0.58731413 |
| 101 | PRKCQ | 0.58363670 |
| 102 | MARK3 | 0.55663758 |
| 103 | PTK2 | 0.55578649 |
| 104 | ALK | 0.54011229 |
| 105 | CAMK2G | 0.53591966 |
| 106 | RPS6KA4 | 0.52599504 |
| 107 | PTK2B | 0.52040309 |
| 108 | PIM2 | 0.50640909 |
| 109 | PDK1 | 0.49504736 |
| 110 | PRKCD | 0.48899449 |
| 111 | GRK5 | 0.48244111 |
| 112 | VRK1 | 0.47050703 |
| 113 | PIK3CA | 0.47009988 |
| 114 | MAPK11 | 0.45676246 |
| 115 | MAPK4 | 0.45168881 |
| 116 | PRKACG | 0.43194855 |
| 117 | IRAK3 | 0.42590050 |
| 118 | DAPK1 | 0.42344000 |
| 119 | RET | 0.41911776 |
| 120 | AKT3 | 0.41625279 |
| 121 | STK4 | 0.40993329 |
| 122 | NEK9 | 0.40065768 |
| 123 | PRKCH | 0.39739600 |
| 124 | TYK2 | 0.39692796 |
| 125 | NME2 | 0.39564916 |
| 126 | JAK3 | 0.38650741 |
| 127 | KDR | 0.38650572 |
| 128 | MAP3K1 | 0.38643283 |
| 129 | MAPK3 | 0.38262166 |
| 130 | MAP3K14 | 0.38104014 |
| 131 | CHUK | 0.38078955 |
| 132 | SIK1 | 0.37939371 |
| 133 | MAPKAPK2 | 0.37886623 |
| 134 | PRKCZ | 0.37652057 |
| 135 | CAMK2B | 0.37431642 |
| 136 | PRKD1 | 0.34215434 |
| 137 | DYRK3 | 0.33480197 |
| 138 | ILK | 0.33044647 |
| 139 | MAP3K8 | 0.32171320 |
| 140 | PAK3 | 0.31826565 |
| 141 | CAMK2D | 0.31132980 |
| 142 | MAP2K4 | 0.30716664 |
| 143 | CDK12 | 0.30679204 |
| 144 | PRKACA | 0.30075378 |
| 145 | PRKAA1 | 0.30035612 |
| 146 | MARK2 | 0.30021405 |
| 147 | CDK5 | 0.28922742 |
| 148 | RPS6KA1 | 0.28253116 |
| 149 | RAF1 | 0.27183874 |
| 150 | TNK2 | 0.26946754 |
| 151 | SGK1 | 0.25903696 |
| 152 | AKT1 | 0.25826547 |
| 153 | STK24 | 0.25057223 |
| 154 | PRKAA2 | 0.24394255 |
| 155 | IGF1R | 0.24310725 |
| 156 | PKN1 | 0.22465625 |
| 157 | MAP3K10 | 0.22049605 |
| 158 | MST4 | 0.21911703 |
| 159 | MUSK | 0.21747979 |
| 160 | PRKCA | 0.19484156 |
| 161 | RPS6KA3 | 0.19358254 |
| 162 | ERBB3 | 0.19054922 |
| 163 | MAPKAPK3 | 0.19049598 |
| 164 | MAPK10 | 0.18661230 |
| 165 | PRKG1 | 0.17783466 |
| 166 | ADRBK2 | 0.17482099 |
| 167 | RPS6KA2 | 0.17310340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.13535641 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.54698603 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.47711653 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.20025970 |
| 5 | Platelet activation_Homo sapiens_hsa04611 | 2.99703445 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.99448574 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.73382247 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57909187 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53569698 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50982980 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48502560 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.46468546 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.45047218 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.35800198 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.33713151 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30117601 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.26731024 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.26637288 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.12652740 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12441479 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.04753662 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.99671930 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98981105 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97041669 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91965331 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87237760 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86679660 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84111084 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78688494 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77616622 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.75189345 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.72304002 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68208621 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.66067374 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62982154 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59791785 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.58342272 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58034794 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.57204358 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54852862 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47786756 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47190951 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44834562 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43958737 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.41336550 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.39058576 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.29108678 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28660552 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28635389 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.27349363 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26574041 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25247653 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.24671998 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23006067 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20159476 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19478045 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18416613 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17714447 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17303097 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15442401 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13447959 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10010592 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 1.09012755 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08176752 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07928671 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07705847 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05674265 |
| 68 | Malaria_Homo sapiens_hsa05144 | 1.04331432 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02665879 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02410260 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02147561 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01558186 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99999964 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99740761 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.99696516 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99102012 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98918366 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.98684096 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98627508 |
| 80 | DNA replication_Homo sapiens_hsa03030 | 0.97914157 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96401172 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95693338 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94757259 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94251831 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93876238 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92824521 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91216537 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91003525 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90788250 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90586613 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88880678 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88843199 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.87911981 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87470605 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85570671 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84688665 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.82443325 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81836336 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81144442 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80487118 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78619905 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77698992 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.76739638 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.75271255 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.74662745 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74507535 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73734167 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73643800 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73233879 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73209912 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73106505 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72783773 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72569227 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.68771537 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64932876 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63939445 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.62330461 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60961669 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60841793 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60421109 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60289828 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56482453 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56160321 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.55788409 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55616419 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54548221 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.54546738 |
| 128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53347419 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.51599642 |
| 130 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51273276 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51174210 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50938173 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48916271 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48588713 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47058394 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46503358 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46121437 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45773404 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45664658 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45475717 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45145351 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.44609968 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44595683 |
| 144 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43884004 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42823341 |
| 146 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42166551 |
| 147 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41319098 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40306655 |
| 149 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40039861 |
| 150 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.39833493 |
| 151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39304608 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38486701 |
| 153 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37915331 |
| 154 | Shigellosis_Homo sapiens_hsa05131 | 0.37874932 |
| 155 | Spliceosome_Homo sapiens_hsa03040 | 0.37418412 |
| 156 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37200801 |
| 157 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37072759 |
| 158 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.36627109 |
| 159 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35538572 |
| 160 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35251845 |
| 161 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34776841 |
| 162 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33828812 |
| 163 | Glioma_Homo sapiens_hsa05214 | 0.33768365 |
| 164 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33716014 |
| 165 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32601541 |
| 166 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32227888 |
| 167 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31950656 |
| 168 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30129103 |
| 169 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28286348 |
| 170 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27698617 |
| 171 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27203348 |
| 172 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26443481 |
| 173 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.25483358 |
| 174 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24420126 |
| 175 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22483089 |
| 176 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21373168 |
| 177 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20047900 |
| 178 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14865878 |
| 179 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.13127966 |
| 180 | Parkinsons disease_Homo sapiens_hsa05012 | 0.12874498 |

